Cynthia Marsh, in Auburn, NH - Registered Nurse

Cynthia Marsh, is a Registered Nurse - Home Health based in Auburn, New Hampshire. Cynthia Marsh is licensed to practice in Massachusetts (license number 208462) and her current practice location is 10 Pleasant Ct, Auburn, New Hampshire. She can be reached at her office (for appointments etc.) via phone at (603) 451-4511.

NPI number for Cynthia Marsh is 1902569346 and her current mailing address is 10 Pleasant Ct, Auburn, New Hampshire. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1902569346.

Contact Information

	Cynthia Marsh,
	10 Pleasant Ct, Auburn, NH 03032-3238
	(603) 451-4511
	Not Available

Provider's Profile

Full Name	Cynthia Marsh
Gender	Female
Speciality	Registered Nurse - Home Health
Location	10 Pleasant Ct, Auburn, New Hampshire
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1902569346
Provider Enumeration Date: 10/21/2021
Last Update Date: 10/21/2021

Medical Identifiers

Medical identifiers for Cynthia Marsh such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1902569346	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
163WH0200X	Registered Nurse - Home Health	208462 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Cynthia Marsh is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Cynthia Marsh, 10 Pleasant Ct, Auburn, NH 03032-3238 Ph: (603) 451-4511	Cynthia Marsh, 10 Pleasant Ct, Auburn, NH 03032-3238 Ph: (603) 451-4511

News Archive

Scientists use nanodiamonds to boost delivery of drug to leukemic cells

By binding multiple molecules of a common leukemia drug with nanodiamonds, scientists from the National University of Singapore (NUS) and University of California, Los Angeles (UCLA) managed to boost the delivery of the drug to leukemic cells and retain the drug within the cells to combat the cancer.

Not all congestion-producing chronic rhinosinusitis infections are the same

Rather, this problem that afflicts some 30 million Americans annually has four severity classifications that could help guide treatment today and help find better treatments in the future, says the lead author on the study published in the November issue of The Laryngoscope.

Study first to document cumulative effect of racial, sexual harrassment

New research at the University of Toronto is the first to empirically document that women who are visible minorities face a double dose of harassment in the workplace, based on both sex and ethnicity.

Risks of cancer and mortality found to be lowest in light drinkers

The risk of mortality, and of developing a number of cancers, is lowest in light drinkers consuming an average of less than one drink per day across their lifetime, and the risk of some cancers increases with each additional drink per week, according to a new study, published this week in PLOS Medicine by Andrew Kunzmann of Queen's University Belfast, and colleagues.

Cynthia Marsh, - Registered Nurse in Auburn, NH